Endocrinology

We have carefully reviewed this court ruling, which addresses the consent of children and young people to the use of puberty suppressing drugs as part of the treatment of gender dysphoria. We consider that the ruling should not have implications for the general ethical or legal framework for childre...

We’ve made innovative adaptations to keep Paediatric diabetes on the radar during the COVID-19 pandemic to improve care and outcomes.

Dr Andrea Srur, Programme Manager for the national Diabetes Quality Programme, describes the recent successes from this project and the challenges presented by the COVID-19 outbreak.

We look ahead to plans for digital growth charts, which will be available to parents and carers in 2021.

The National Paediatric Diabetes Audit (NDPA) 2018/19 Annual Report on Care Processes and Outcomes was published today by the Royal College of Paediatrics and Child Health (RCPCH).

Our annual, national reports, 'Care processes and outcomes' highlight the main findings on the quality of care for children and young people with diabetes mellitus in England and Wales. On this page you can download our latest and previous reports, and find links to our reports especially for parent...

Small grants for basic scientists and AHP's. Supports early-career researchers to undertake small research projects related to diabetes, with the aim of enabling successful recipients to go on to secure further, more significant, funding

DRWF Research Fellowships are given for research related to causes, cures or complications of diabetes

On 4 June 2021, the National Paediatric Diabetes Audit (NPDA) held their National Conference online via Microsoft Teams. Staff from all professional groups working in diabetes and other stakeholders came together to learn about how NPDA data has been used to improve services and to inform best pract...

NHSE is conducting a review of the specification for this service and associated policies for 2020. It will also set up an independent expert group to make recommendations regarding the use of puberty suppressants and cross-sex hormones.